Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Firearm Injuries Tied to Long-Term Physical, Functional Health Challenges

Survivors of firearm injuries often experience long-term physical and functional health challenges, according to a study published online Jan. 26 in the Journal

Moderna’s mRNA Flu Vaccine Back Under FDA Review

THURSDAY, Feb. 19, 2026 In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna s experimental mRNA influenza vaccine. Th

Capacitive-Resistive Monopolar Radiofrequency Appears Safe, Effective for Genitourinary Syndrome of Menopause

Capacitive-resistive monopolar radiofrequency significantly improved sexual function and vaginal health in women with genitourinary syndrome of menopause, accor

Wildfire Smoke Exposure During Pregnancy May Increase Autism Risk in Offspring

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a study published in the February issue of Envir

Nighttime Road Traffic Noise Tied to Higher Cholesterol, Blood Lipid Levels

Nighttime road traffic noise exposure is associated with alterations in blood cholesterol and lipid profiles in adults, according to a study published in the Ma

Short-Term Surgical Outcomes at Rural Facilities Similar to Those in More Distant, Urban Facilities

Older patients with stage I to III colon or lung cancer achieve comparable short-term surgical outcomes when they undergo surgery at local rural facilities vers

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA PF’3944 Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Pfizer Inc. (NYSE PFE) today announced positive topline results from the Phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, u

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program

Cumberland Pharmaceuticals Inc. (Nasdaq CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investig

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

CAMBRIDGE, MA ACCESS Newswire February 10, 2026 Moderna, Inc. (NASDAQ MRNA) today announced the U.S. Food and Drug Administration s (FDA) Center for Biologics E

Popular Keywords